Keeping the spleen during left-sided pancreas cancer surgery
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study compares two ways to remove a tumor from the left side of the pancreas: one that also removes the spleen, and one that tries to keep the spleen. Keeping the spleen may lower the risk of infections later, but the trial will check if it is as safe and effective as removing it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older
- Have pancreatic cancer that is in the body, neck, or tail of the pancreas and is either removable without prior treatment or removable after some neoadjuvant (pre-surgery) therapy
- The planned surgery must be feasible to spare the spleen (based on tumor location and distance from the spleen)
- Have no evidence of tumor involvement of lymph nodes near the spleen on imaging
- Have no prior abdominal surgery that cut the blood vessels that supply the stomach and spleen (like gastric bypass, sleeve gastrectomy, or fundoplication)
- Be fit for surgery as determined by your surgeon and anesthesiologist
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares robot-assisted surgery with standard keyhole surgery to remove growths on the left side of the pancreas. It may help doctors determine which method is safer and more effective for non-cancerous or pre-cancerous conditions.
This study tests a cooling device (Coolingbis®) that is attached to the pancreas during surgery to remove the left side of the pancreas. The device aims to reduce damage to the remaining pancreas tissue, which may help preserve its function and reduce complications.
This study looks at how the surgeon's cutting edges (margins) and the way the tumor sits in the pancreas affect outcomes for people having surgery for pancreatic cancer. By joining, you'll help researchers learn how to improve surgery and planning for future patients.
This trial compares two laparoscopic techniques to remove tumors from the pancreas while keeping the spleen. The goal is to see which method is safer and better for people with non-cancerous or low-grade tumors.
This trial tests whether removing the spleen during open surgery for infected dead pancreas tissue helps people with a specific type of high blood pressure around the spleen caused by severe pancreatitis. It may lower bleeding risk and improve recovery.
This trial compares two ways of doing surgery in people with early, left-sided pancreatic cancer that can be removed. It may help find the approach with better outcomes while aiming to keep the operation safe and effective.
Hear when a new Pancreatic cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.